Error: Could not add to watchlist. X

SEB Concept Biotechnology

+ Watchlist
BFGCBIO:LX
129.73
EUR
2.28
1.73%
As of 00:59:30 ET on 07/27/2015.
Fund Type
FCP
52Wk Range
79.15 - 139.62
1 Yr Return
59.82%
YTD Return
26.03%
Previous Close
132.01
52Wk Range
79.15 - 139.62
1 Yr Return
59.82%
YTD Return
26.03%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/27/2015)
129.726
Total Assets (m EUR) (on 07/27/2015)
673.992
Inception Date
10/16/2000
Last Dividend (on 01/16/2015)
0.2021
Dividend Indicated Gross Yield
0.16%
Fund Managers
ULRIKA BERGMAN
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.50%
Expense Ratio
1.80%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 554.60 k 58.28 m 9.23
Amgen Inc 415.30 k 57.22 m 9.07
Biogen Inc 141.92 k 51.45 m 8.15
Celgene Corp 387.50 k 40.25 m 6.38
Regeneron Pharmaceuticals Inc 75.28 k 34.46 m 5.46
Alexion Pharmaceuticals Inc 178.99 k 29.04 m 4.60
Mylan NV 471.65 k 28.73 m 4.55
Endo International PLC 304.58 k 21.77 m 3.45
Shire PLC 91.74 k 19.88 m 3.15
Jazz Pharmaceuticals PLC 119.70 k 18.92 m 3.00
Profile
SEB Concept Biotechnology is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve long-term capital appreciation. The Fund invests globally in equities and equity-related securities of issuers from the biotechnology sector.
ADDRESS
ST/S6, 106 40
Stockholm
PHONE
352-2-66-82-1 Tel